Thursday, June 02, 2022 6:32:22 PM
Recent RPTX News
- Repare Therapeutics Announces New Data Underscoring Need for Additional Treatment Solutions for Patients with Metastatic Gynecologic Cancers • Business Wire • 09/23/2024 11:05:00 AM
- Repare Therapeutics to Present Data from Phase 1/2 TRESR Clinical Trial Evaluating Camonsertib Monotherapy in Multiple Advanced Solid Tumors Harboring ATM Loss-of-Function at ESMO Congress 2024 • Business Wire • 09/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:15:31 PM
- Repare Therapeutics Announces Strategic Reprioritization to Focus on Broad Clinical Portfolio • Business Wire • 08/28/2024 08:05:00 PM
- Repare Therapeutics to Participate in Two Upcoming Investor Conferences • Business Wire • 08/27/2024 11:05:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/20/2024 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 01:06:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/06/2024 08:41:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:11:38 PM
- Repare Therapeutics Provides Business and Clinical Update and Reports Second Quarter 2024 Financial Results • Business Wire • 08/06/2024 08:05:00 PM
- Alberta Enterprise Corporation invests US$7.5 million into Amplitude precision medicine fund • PR Newswire (Canada) • 07/16/2024 01:00:00 PM
- Repare Therapeutics Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI • Business Wire • 06/26/2024 02:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:05:54 PM
- Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial • Business Wire • 06/10/2024 11:05:00 AM
- Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer • Business Wire • 06/04/2024 08:05:00 PM
- Repare Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/03/2024 08:05:00 PM
- Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024 • Business Wire • 05/29/2024 11:05:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/24/2024 08:06:52 PM
- Small Cap Massively Bid Following Key Q1 Earnings Beat • AllPennyStocks.com • 05/08/2024 02:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:15:55 PM
- Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results • Business Wire • 05/07/2024 08:05:00 PM
- Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition • Business Wire • 04/30/2024 11:05:00 AM
- DEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT D’UN PREMIER PATIENT DANS LE CADRE DE L’ÉTUDE DE PHASE 1/1B MYTHIC ÉVALUANT LA COMBINATION D’INHIBITEURS WEE1 ET PKMYT1 GÉNÉRANT UNE LÉTHALITÉ SYNTHÉTIQUE • Business Wire • 04/30/2024 11:05:00 AM
- Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition • Business Wire • 04/30/2024 11:05:00 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM